🇺🇸

Distress Insolvency

· daily

US Corporate Distress Financial Stress SEC Filings — June 05, 2026

This batch of 48 SEC filings reveals a pronounced bifurcation in corporate health, with a cluster of companies in acute distress—evidenced by forbearance agreements, Nasdaq deficiency notices, and distressed debt exchanges—while others execute strategic refinancings and capital raises. The most critical themes are a wave of liquidity crises among small-cap industrials and tech firms, aggressive debt refinancing at higher costs signaling credit stress, and a surge in at-the-market (ATM) equity offerings that dilute existing shareholders. Period-over-period data, where available, shows revenue declines and cash burn rates that are unsustainable, with several companies having less than six months of runway. Conversely, a few companies like Brown & Brown and Synchrony Financial are successfully accessing capital markets on favorable terms, indicating a healthy credit environment for investment-grade entities. The overall picture is one of increasing divergence, where well-capitalized firms are strengthening their balance sheets while weaker players face existential threats, creating both high-risk and high-opportunity scenarios for investors.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 04, 2026

This intelligence stream reveals a significant bifurcation in corporate health across 48 filings. A dominant theme is acute liquidity distress among micro-cap and pre-revenue companies, with 10+ filings involving emergency insider loans, distressed debt exchanges, or going-concern warnings. Concurrently, a wave of capital markets activity—including $1.2B+ in new debt and equity offerings—signals both opportunistic refinancing and desperate cash grabs. Notable period-over-period trends include a sharp increase in refinancing costs (e.g., B&G Foods' coupon jumping from 5.25% to 11.00%) and a surge in spin-off/divestiture activity aimed at unlocking value. Insider activity is sparse but telling, with related-party loans and CFO departures flagging governance risks. The most critical developments include multiple Nasdaq non-compliance notices, a $2.0B non-binding financing term sheet with a $25M non-refundable fee, and a $50M antitrust settlement. The overall market implication is a 'flight to quality' where companies with strong balance sheets are capitalizing on dislocation, while weaker players face a binary outcome.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 03, 2026

This batch of 46 filings reveals a pronounced bifurcation in US public markets: a wave of deeply distressed micro-caps engaging in emergency financing, reverse splits, and delinquent filings contrasts sharply with a handful of fundamentally sound companies opportunistically refinancing and securing transformational government backing. The dominant theme is acute liquidity stress, with at least 15 companies executing dilutive capital raises (debt/equity), 5 companies receiving NYSE/Nasdaq deficiency or delisting notices, and 3 firms filing for or teeing up Chapter 11 restructuring. Period-over-period data, where available, confirms deteriorating trends: Katapult's multiple loan waivers, Kingfish's shift to 90-day loan extensions, and Reed's sub-$4M equity underscore systemic working capital crises. On the positive side, USA Rare Earth's $1.6B CHIPS Act funding, Mineralys' $200M buyout of royalty obligations, and TTM Technologies' 50bps Term Loan B repricing highlight strategic wins. Insider activity is predominantly neutral/absent in these filings, but several director-led placements (IR-Med, Range Impact) signal insider alignment albeit at distressed levels. The most actionable signal is the impending Inotiv prepackaged Chapter 11 filing—the highest materiality event in this batch—while the deteriorating covenant compliance patterns at Katapult and Kingfish demand immediate monitoring.

46 high priority 46 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — June 03, 2026

This session was extremely quiet with only one pre-analyzed filing: Inotiv, Inc.'s 8-K detailing a prepackaged Chapter 11 plan of reorganization. The filing signals a structured, consensual restructuring attempt, supported by a substantial majority of claim holders, which reduces the risk of a contentious bankruptcy. However, the company has not yet filed the Chapter 11 petition, and the disclosure statement remains unapproved by the court, creating procedural uncertainty. The pre-petition solicitation is limited to accredited investors and QIBs, indicating a targeted approach to secure plan confirmation. The negative sentiment and high materiality (10/10) underscore a critical juncture for Inotiv's capital structure and equity value. With no other filings in the stream, the focus is entirely on the execution and timeline of this restructuring, with the vote deadline of July 6, 2026, as the next key catalyst.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 02, 2026

The 48 filings in this intelligence stream reveal a bifurcated corporate landscape dominated by aggressive capital restructuring, elevated refinancing activity, and a clear 'survival of the fittest' dynamic. A significant cohort of companies, particularly in energy and industrials (Hallador, Granite Construction, Peabody), are executing transformative, multi-billion dollar projects or recapitulations, often accompanied by high-yield debt offerings at rates of 6.375% to 7.75%, signaling both conviction and a high cost of capital. Simultaneously, a cluster of micro-cap and stressed entities (Tempest Therapeutics, C2 Blockchain, NKGen Biotech) are resorting to deeply dilutive financings and convertible notes with 10% OIDs to secure small cash infusions, effectively worsening their equity positions for near-term liquidity. The data shows a strong trend of liability management and covenant amendments—from Atlantic American Corp needing a waiver for financial statement delivery to Curbline Properties launching a $400M ATM to scout for acquisitions. A nascent thematic is the emergence of insider-driven 'recapitalizations,' like Greenpro Capital's CEO and LQR House's controlling stake purchase in profitable assets, suggesting that management sees intrinsic value despite market skepticism. The most actionable insight is the prevalence of M&A as both a distress signal and an opportunity, with the NCS Multistage/Weatherford and Arxis/Ominetics deals providing clear floor prices, while the Hertz ABS issue at rates up to 9.64% flags acute credit risk in the rental car sector. Overall, the market is pricing in high uncertainty, favoring deep-dive credit analysis and event-driven plays over broad sector exposure. Key forward-looking catalysts are heavily loaded in late 2026 and 2028, making the next 6-12 months a critical period for execution on these announced plans.

48 high priority 48 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — June 01, 2026

This intelligence digest synthesizes 50 pre-analyzed SEC filings from June 1, 2026, revealing a pronounced bifurcation in corporate health. While 12 companies are executing aggressive capital structure improvements (e.g., FedEx Freight spin-off, Bright Horizons refinancing, Dropbox buyback), the distress stream is dominated by 8 high-risk bankruptcy/going-concern signals, including a Chapter 11 filing (Trinseo), multiple missed interest payments (Inotiv), and Nasdaq delisting threats (iSpecimen, Nuburu, HCW Biologics). A clear sector theme emerges: capital-intensive industries (energy, manufacturing, REITs) are actively de-levering, while cash-burning biotechs and small-cap tech firms face acute liquidity crises. Insider activity is sparse but notable, with Chairman Einhorn's share repurchase agreement at Greenlight Capital Re signaling tax-driven ownership management. Forward-looking data points to a catalyst-rich Q3 2026, with major M&A closings (Taylor Morrison, Edgewise/Servier) and critical regulatory deadlines (Nuburu's Italian Golden Power approval). The most actionable insights lie in the distressed debt space, where companies like System1 and Optimum Communications are executing complex restructurings that could unlock significant value for patient capital.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 29, 2026

The 49 filings reveal a surge in corporate distress signals, with 10 companies receiving Nasdaq non-compliance or delisting notices, primarily due to late filings or equity deficiencies. Notable distress includes Aditxt (negative equity of -$35M), Edible Garden (imminent suspension), and Gulf Resources (multiple delinquencies). Capital markets activity is mixed: several companies raised debt (Xylem $1B, Kennedy-Wilson $1.8B, Navient $500M) or equity (Momentus $25M, Wellgistics $21.1M), while others like GrafTech and Solana expanded ATM programs. M&A activity continues with Cycurion acquiring Secuvant for $3M, CoStar buying Zonda for $800M, and Healthy Choice Wellness acquiring Host Digital. Insider trading data is sparse, but the high number of going concern warnings and equity issuances suggests management caution. Period-over-period comparisons are limited as most filings are event-driven, but Avalanche Treasury's net loss of $139,635 and zero cash highlight severe cash burn. The overall theme is a bifurcated market: well-capitalized firms access debt markets cheaply, while distressed micro-caps scramble for survival.

49 high priority 49 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 28, 2026

The 49 filings from May 28, 2026, reveal a market bifurcated between aggressive corporate actions (M&A, refinancing) and acute financial distress, particularly among small-cap and micro-cap companies. A dominant theme is the wave of refinancing and debt restructuring, with companies like Kinder Morgan, Hexcel, PBF Energy, and Kennametal extending maturities and managing balance sheets, while distressed entities like Nature's Miracle, Celularity, and Allbirds engage in survival-mode settlements and covenant amendments. Distress signals are concentrated in Nasdaq compliance failures, with Lulu's Fashion Lounge, CDT Equity, and Richtech Robotics receiving deficiency notices, and distressed financing (PIPEs, high-interest loans) from ENDRA Life Sciences, Vestand, and Polaryx Therapeutics. On the opportunity side, high-value M&A is a key catalyst, including the $17.6B acquisition of Caesars Entertainment, Autodesk's $3.6B acquisition of MaintainX, and Apogee Enterprises' accretive acquisition of Kalwall. Sector themes point to a capital rotation from distressed small-caps to larger, cash-rich acquirers, with energy infrastructure (Cheniere, Sabine Pass) and AI infrastructure (Boost Run) seeing significant long-term investment commitments. The overall sentiment is cautiously optimistic for large caps with strong balance sheets, but highly bearish for micro-caps facing liquidity crises and potential delisting.

49 high priority 49 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 27, 2026

The 50 filings from May 27, 2026, paint a stark picture of a bifurcated market: a wave of distressed micro-caps is aggressively seeking emergency capital through dilutive ATMs, convertible notes, and private placements, while larger, more stable companies are opportunistically refinancing debt and pursuing strategic M&A. The most critical theme is the surge in Nasdaq non-compliance and going-concern risks, with at least five companies (Borealis Foods, Greenwave Technology, Liminatus Pharma, SOBR Safe, Callan JMB) facing potential delisting. This distress is concentrated in the small-cap biotech and technology sectors, where cash burn and failed trials are forcing existential restructuring. In contrast, the energy and digital infrastructure space is seeing significant capital deployment, highlighted by DigitalBridge's $1.05B acquisition of ArcLight and newcleo's $2.4B SPAC merger. Insider activity is notably absent from these filings, but capital allocation patterns—aggressive dilution vs. strategic debt refinancing—clearly separate the survivors from the distressed. The period-over-period data from BDCs (Golub Capital, PennantPark) shows flat-to-declining net asset values, signaling a cautious outlook for credit markets. The most actionable intelligence lies in the distressed names where the structure of rescue financing (e.g., HWH International's control-diluting deal) creates both extreme risk and potential for asymmetric returns.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 26, 2026

The 42 filings from May 26, 2026, paint a stark picture of a bifurcated US corporate landscape. While a handful of companies (Ares Capital, IREN, Allied Gaming) are executing large-scale, growth-oriented capital raises and acquisitions, a significant cohort is exhibiting classic distress signals. The most critical development is Trinseo PLC's Chapter 11 filing, which confirms a major restructuring in the chemicals sector and serves as a high-severity warning for other over-levered industrials. A secondary wave of distress is evident in the micro-cap and biotech space, with at least five companies (Nuvve, Vestand, TEN Holdings, World Acceptance, Future FinTech) receiving Nasdaq deficiency notices or requiring covenant relief, indicating systemic liquidity pressure. The dominant theme is a 'flight to quality' in capital markets, where well-capitalized firms easily access billions in credit (Ares, Encore Capital), while distressed entities are forced into dilutive equity offerings (Editas, Assembly Biosciences) or high-cost debt (LiqTech, Future FinTech). Insider activity, where observable, is mixed, but the pattern of repeated debt extensions (Odyssey Health) and governance changes to centralize control (Motorsport Games) are clear red flags for equity holders. The forward-looking data reveals a catalyst-rich calendar, with several Phase 3 clinical trial readouts (Cartesian, Editas) and transformative M&A closings (Allied Gaming, Northern Oil & Gas) that will define the next quarter's winners and losers.

42 high priority 42 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — May 26, 2026

The single filing processed on May 26, 2026, for Trinseo PLC represents a final-stage corporate distress event: a prepackaged Chapter 11 filing. While the filing lacks comparative period metrics for Trinseo itself, the decisive nature of the action—supported by a supermajority of debt holders—signals a clean, creditor-led restructuring. The key development is the planned elimination of approximately $2.0 billion in debt and a roughly $140 million annual interest expense reduction, drastically reshaping the capital structure. However, the explicit confirmation that existing equity will receive no recovery makes this a watershed moment for shareholders, effectively zeroing out the current equity value. The market implication is bifurcated: debt holders are positioned for a controlled recovery, while common equity is rendered worthless. The filing's high materiality score (10/10) and negative sentiment underscore the total loss for equity investors and highlight the speculative risk of trading stock during proceedings.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 22, 2026

The 50 filings reveal a surge in corporate distress signals, with 12 companies receiving Nasdaq deficiency notices for late filings or equity shortfalls, and several others engaging in dilutive financing or asset sales to shore up liquidity. Key themes include a wave of going-concern warnings, aggressive capital raises via convertible notes and ATM offerings, and strategic pivots into AI and digital infrastructure. Notable positive signals include Crescent Energy's credit facility expansion and Corpay's refinancing, which lower borrowing costs and extend maturities. However, the prevalence of insider selling, covenant breaches, and delayed filings underscores a fragile environment for small-cap and micro-cap issuers. Investors should focus on companies with strong period-over-period revenue growth and insider buying, while avoiding those with repeated compliance failures and negative sentiment.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 21, 2026

The 50 filings reveal a bifurcated market with aggressive capital raising and strategic portfolio reshaping amid rising distress signals. A dominant theme is the wave of equity and debt offerings, with 12 companies raising capital through dilutive stock sales, convertible notes, or private placements, signaling acute cash needs. Concurrently, major portfolio optimization is underway, highlighted by the $69 billion AvalonBay/Equity Residential merger of equals and significant divestitures by Kontoor Brands (Lee® for up to $1B), Conduent (Public Transit for $164M), and Sun Communities (UK assets for ~$1.03B). Distress is concentrated among micro-cap biotechs and struggling tech firms, with 4 companies executing reverse stock splits to maintain exchange listings and 2 receiving delisting notices. Period-over-period data, though limited, shows mixed results: Hims & Hers grew revenue 44.8% YoY but missed guidance, while Picard Medical grew revenue 85% YoY but saw net losses widen. Insider activity is sparse, but the prevalence of related-party transactions and distressed financings suggests management is prioritizing survival over shareholder value. The overall sentiment is cautious, with a clear trend toward deleveraging, portfolio simplification, and reliance on capital markets for liquidity.

50 high priority 50 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 20, 2026

The 47 filings from May 20, 2026, reveal a bifurcated corporate landscape: a surge in distress signals (bankruptcies, delistings, liquidity crises) is concentrated in small-cap and pre-revenue tech/healthcare names, while larger, established firms are proactively refinancing debt and optimizing capital structures. Key period-over-period trends show a stark contrast, with companies like Curtiss-Wright reporting 12% YoY revenue growth but a 4.4% decline in net income, highlighting margin pressure, while Golden Minerals improved its net loss by 50% YoY but faces a severe cash crunch. The most critical developments include the Chapter 11 filing of Society Pass, multiple Nasdaq delisting notices (TOMI, Socket Mobile, Singularity Future), and a transformative but high-risk merger for Envirotech Vehicles. Portfolio-level patterns reveal a 'flight to quality' in debt markets, with investment-grade issuers like Gilead and Williams Companies accessing large, low-cost facilities, while distressed firms are forced into dilutive equity or debt-for-equity swaps. The overall market implication is one of increasing credit divergence, where access to capital is a key differentiator between survival and failure.

47 high priority 47 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 19, 2026

The 40 filings from May 19, 2026, paint a picture of a market bifurcated between aggressive capital management and acute distress. While several firms (STORE Capital, Diversified Energy, Kimbell Royalty) are successfully refinancing debt at lower rates or making accretive acquisitions, a significant cluster of companies is exhibiting classic pre-bankruptcy distress signals. Bitcoin Depot has already filed for Chapter 11 and faces delisting, while TechPrecision, Zoomcar, and Aether Holdings are executing last-resort financing or settlement agreements that signal severe liquidity constraints. The period-over-period data reveals a troubling trend: revenue growth is anemic or negative for many, with net losses widening dramatically (MSP Recovery's loss doubled to $457.8M, Eagle Materials' earnings fell 9% despite record revenue). A wave of dilutive equity offerings (GeoVax, Rapid Micro, Sunshine Biopharma) and distressed debt exchanges (Jaguar Health, InMed) suggests a 'cash-for-equity' cycle is accelerating among micro-cap and clinical-stage biotechs. The most actionable insight is the stark contrast between well-capitalized firms using favorable debt markets to lock in low rates and distressed entities burning through their last options, creating a clear 'haves vs. have-nots' dynamic in the current credit environment.

40 high priority 40 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 18, 2026

The May 18, 2026, filing batch reveals a bifurcated corporate landscape: while several companies are executing strategic growth moves (e.g., CoreWeave's $3.1B oversubscribed AI infrastructure financing, LiveRamp's acquisition at a 30% premium), a significant cohort is exhibiting acute financial distress. The most critical signal is Bitcoin Depot's bankruptcy filing (Item 1.03), representing a total equity wipeout for shareholders. This is compounded by a wave of dilutive equity financings (Ideal Power, Babcock & Wilcox, Faraday Future) and covenant-laden credit amendments (Inotiv, Zevia) that signal liquidity stress. A notable pattern is the surge in capital markets activity, with $4.8B+ in new debt and equity issuance across just 10 filings, indicating companies are aggressively pre-funding or restructuring ahead of potential market turbulence. Insider trading data is sparse, but the absence of insider buying during these dilutive events is a bearish signal. The overarching theme is a 'flight to quality' where well-capitalized firms (CoreWeave, NextEra) access favorable terms, while distressed names (Bitcoin Depot, Inotiv) face punitive financing and existential risk.

50 high priority 50 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — May 18, 2026

The sole filing in today's bankruptcy intelligence stream is a comprehensive 8-K from Bitcoin Depot Inc., signaling a critical bankruptcy or receivership event (Item 1.03) combined with triggered financial obligations and executive departures. This filing represents a total equity value destruction event for shareholders, with the company—a Bitcoin ATM operator—facing likely Chapter 11 proceedings or similar restructuring. The enriched data reveals no period-over-period comparisons, insider activity, or forward-looking guidance, as the filing is a binary event disclosure rather than a periodic report. The bearish sentiment and critical risk level are fully justified, as the multiple 8-K items (1.03, 2.04, 5.02, 7.01, 9.01) indicate a comprehensive and severe financial collapse. Creditors face uncertain recovery rates, and the crypto-adjacent sector adds regulatory complexity. This is a singular, high-severity event with no portfolio-level trends to aggregate, but it serves as a stark reminder of the risks in the Bitcoin ATM and broader crypto infrastructure space.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 14, 2026

Across 50 8-K filings in the USA Corporate Distress & Bankruptcy stream (May 14, 2026 period), overarching themes include aggressive debt refinancing (25+ issuances/amendments totaling billions, e.g., Lumen $2.4B, IREN $3B, Constellation $2.2B) to extend maturities and repay near-term obligations, signaling proactive deleveraging amid higher rates rather than outright insolvency. Explicit distress peaks with Trinseo's $2B debt-cut RSA via pre-pack Chapter 11, Society Pass's Chapter 11 filing, and FREIT's liquidation plan (60-97% premium), representing 6% of filings but high materiality (10/10). Where period data available, trends mixed: Applied Materials +11% YoY revenue, +0.8pts gross margin to 49.9%, EPS +33% YoY contrasts HyOrc/GridAI dilutive raises; no broad insider selling/buying patterns noted. Capital allocation favors refinancings/repayments over dividends/buybacks (e.g., AEP forward sales, Tyler $1.4B notes + repurchases). Forward catalysts cluster in Q3 2026 (acquisitions, closings). Portfolio-level: moderate distress with refinancings mitigating bankruptcy risks, but REIT/energy small caps vulnerable; relative outperformance in semis/utilities.

50 high priority 50 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — May 14, 2026

The USA Bankruptcy & Insolvency stream features a single high-materiality (10/10) Chapter 11 filing by Society Pass Incorporated (SOPA), signaling acute financial distress in the travel and media sectors. No period-over-period financial trends are detailed in the filing, but the voluntary petition implies severe liquidity constraints and operational challenges culminating in bankruptcy on May 12, 2026. Key developments include joint administration in the Southern District of Texas, operations continuing as debtors-in-possession, and a default under the Prepetition Insurance Agreement with automatic stay on enforcement. Equity trading on Nasdaq is deemed highly speculative with substantial risks, likely leading to significant shareholder value erosion. Negative sentiment dominates, with no bullish indicators from insider activity, capital allocation, or forward-looking guidance beyond first-day motions. Portfolio-level implications highlight insolvency risks for small-cap travel/media firms amid economic pressures.

1 high priority 1 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 13, 2026

Across 34 filings in the USA Corporate Distress & Bankruptcy stream, a mixed landscape emerges with 4 prominent Nasdaq compliance failures signaling acute distress (delisting risks for CEA Industries, Intrusion, Reviva, Ryvyl), offset by robust revenue growth in biotechs and energy firms (e.g., Aquestive +66% YoY, Eos +445% YoY, Allogene R&D expenses -36% YoY). Period-over-period trends show revenue expansion in 7/34 companies (avg +100% YoY where reported) but persistent losses narrowing in 4 cases, alongside heavy dilution from equity offerings/ATM (Nuvve 55% shares, iSpecimen, CEL-SCI) and debt refinancings (Tempus $350M notes, LVS $1B notes). Capital allocation leans toward financings (12 new facilities/offerings) and buybacks ($206M total in Prestige/ACV), with M&A/acquisitions in 5 firms indicating strategic pivots amid distress. Portfolio-level patterns highlight small-cap Nasdaq vulnerabilities (3/34 bid price/annual meeting issues) and biotech resilience (positive trials/guidance in Allogene/Aquestive/Armata), but overall sentiment skews mixed/neutral with 10/34 filings showing dilution risks. Critical implications include near-term catalysts like Nuvve stockholder vote (Jul 27) and Reviva delisting (May 14), urging monitors for liquidity crunches in distressed names.

34 high priority 34 total filings